Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Merck & Co. Inc
MRK | US
111.90
USD-2.72
-2.37%
MRK | US
Loading StockChartView...
About Merck & Co. Inc
Sector
Healthcare
Industry
Drug Manufacturers - Major
Earnings date
30/06/2024
As of date
24/04/2026
Close
111.90
Open
113.74
High
114.03
Low
111.50
Merck & Co. Inc. operates as a healthcare company worldwide. It operates through two segments Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology hospital acute care immunology neuroscience virology cardiovascular and diabetes as well as vaccine products such as preventive pediatric adolescent and adult vaccines. The Animal Health segment discovers develops manufactures and markets veterinary pharmaceuticals vaccines and health management solutions and services as well as digitally connected identification traceability and monitoring products. The company serves drug wholesalers and retailers hospitals and government agencies; managed health care providers such as health maintenance organizations pharmacy benefit managers and other institutions; and physicians and physician distributors veterinarians and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co. Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co. Inc. was founded in 1891 and is headquartered in Rahway New Jersey.
View LessMRK | US
Risk
28.9
Sharpe
1.50
Luna's Score
60/100
Recommendation
Hold
Luna says (MRK | US)
What's Working
Low 6-Month Volatility (<30%)
Megacap (>200B USD)
Good Dividend Yield (2% <= Dividend Yield <= 8%)
Low Market Beta (-0.4 to 0.8)
Strong Operating Margin (> 25%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
Weak P/E, and PEG ratio indicator
High Debt to Equity (> 0.75)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
30.8%1 month
28.9%3 months
25.8%6 months
26.5%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
20.13
Fwd. PE
11.12
Price to book
6.38
Debt to equity
0.87
Debt to assets
0.34
Ent. to EBITDA
14.80
Ent. to rev.
4.88
PEG
0.07
Other Fundamentals
EBITDA
23.63B
MarketCap
283.65B
MarketCap(USD)
283.65B
Div. yield
2.81
Op. margin
43.55
Erngs. growth
68.50
Rev. growth
7.20
Ret. on equity
33.38
Short ratio
2.70
Short perc.
1.08
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
11.51
Range1M
12.50
Range3M
19.11
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.78
Price X volume
789.89M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 14.80 | 21.06 | Cheaper |
| Ent. to Revenue | 4.88 | 5.64 | Par |
| PE Ratio | 20.13 | 41.17 | Cheaper |
| Price to Book | 6.38 | 11.46 | Cheaper |
| Dividend Yield | 2.81 | 3.27 | Par |
| Std. Deviation (3M) | 25.82 | 39.12 | Lower Risk |
| Debt to Equity | 0.87 | 1.72 | Cheaper |
| Debt to Assets | 0.34 | 0.31 | Par |
| Market Cap | 283.65B | 200.67B | Market Leader |
